%0 Journal Article
%A Uras, Iris Z
%A Walter, Gina
%A Scheicher, Ruth
%A Bellutti, Florian
%A Prchal-Murphy, Michaela
%A Tigan, Anca S
%A Valent, Peter
%A Heidel, Florian H
%A Kubicek, Stefan
%A Scholl, Claudia
%A Fröhling, Stefan
%A Sexl, Veronika
%T Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.
%J Blood
%V 127
%N 23
%@ 1528-0020
%C Stanford, Calif.
%I HighWire Press
%M DKFZ-2017-05779
%P 2890 - 2902
%D 2016
%X Up to 30
%K Mutant Proteins (NLM Chemicals)
%K Piperazines (NLM Chemicals)
%K Protein Kinase Inhibitors (NLM Chemicals)
%K Proto-Oncogene Proteins (NLM Chemicals)
%K Pyridines (NLM Chemicals)
%K FLT3 protein, human (NLM Chemicals)
%K fms-Like Tyrosine Kinase 3 (NLM Chemicals)
%K PIM3 protein, human (NLM Chemicals)
%K Protein-Serine-Threonine Kinases (NLM Chemicals)
%K CDK6 protein, human (NLM Chemicals)
%K Cyclin-Dependent Kinase 6 (NLM Chemicals)
%K palbociclib (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:27099147
%2 pmc:PMC4920675
%R 10.1182/blood-2015-11-683581
%U https://inrepo02.dkfz.de/record/130701